Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Ebola virus-like particles prevent lethal Ebola virus infection

10.12.2003


Scientists have successfully immunized mice against Ebola virus using hollow virus-like particles, or VLPs, which are non-infectious but capable of provoking a robust immune response. These Ebola VLPs conferred complete protection to mice exposed to lethal doses of the virus.



The work could serve as a basis for development of vaccines and other countermeasures to Ebola, which causes hemorrhagic fever with case fatality rates as high as 80 percent in humans. The virus, which is infectious by aerosol, is of concern both as a global health threat and a potential agent of biological warfare or terrorism. Currently there are no available vaccines or therapies.

In a study published in this week’s online edition of Proceedings of the National Academy of Sciences, Sina Bavari and colleagues at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) describe creating VLPs from two Ebola virus proteins, glycoprotein (GP) and matrix protein (VP40). These VLPs resemble a shell of infectious viral particles but lack the genetic material necessary for reproduction.


When the VLPs were injected into mice, they activated both arms of the immune response. Specifically, they induced cell-mediated immunity via T cells and humoral immunity via B cells. Both are necessary for complete protection against the Ebola virus.

Having shown that the VLPs evoked a robust immune response, the team next examined whether this response could protect mice from lethal challenge with Ebola virus. Mice were vaccinated with VLPs three times at three-week intervals and challenged with the virus six weeks after the last vaccination. The result was 100 percent protection with no signs of illness in the immunized mice.

"This is astonishing work," said Colonel Erik A. Henchal, commander of USAMRIID. "The ability to produce self-assembling particles that resemble whole virus will give us a new tool to evaluate the combination of variables required to produce a protective immune response to Ebola virus."

According to Bavari, VLPs have already been tested and found efficacious as vaccines for several other viruses, including papillomavirus, HIV, parvovirus, and rotavirus. His team hopes to build upon its work by evaluating the efficacy of VLPs for both Ebola and Marburg, a related virus, in nonhuman primates.

"The beauty of this approach is that VLPs are not a traditional vaccine platform, so you don’t have to worry about the recipient building up an immunity to that platform," Bavari explained. "It looks like a virus, so you have the protective immune response, but it’s basically an empty shell."

VLPS also have potential application beyond vaccine development--for example, they could be used to develop diagnostic reagents for identifying Ebola-infected samples. In addition, generating VLPs containing additional structural proteins will be useful in determining the mechanisms of the immune responses to Ebola virus infection.

Study collaborators were Kelly L. Warfield, Catharine M. Bosio, Brent C. Welcher, Emily M. Deal, Alan Schmaljohn, and M. Javad Aman, all of USAMRIID, and Mansour Mohamadzadeh of the Department of Medicine at Tulane University.


USAMRIID, located at Fort Detrick, Maryland, is the lead laboratory for the Medical Biological Defense Research Program, and plays a key role in national defense and in infectious disease research. The Institute’s mission is to conduct basic and applied research on biological threats resulting in medical solutions (such as vaccines, drugs and diagnostics) to protect the warfighter. USAMRIID is a subordinate laboratory of the U.S. Army Medical Research and Materiel Command.

Caree Vander Linden | EurekAlert!
Further information:
http://www.usamriid.army.mil/

More articles from Health and Medicine:

nachricht Usher syndrome: Gene therapy restores hearing and balance
25.09.2017 | Institut Pasteur

nachricht MRI contrast agent locates and distinguishes aggressive from slow-growing breast cancer
25.09.2017 | Case Western Reserve University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: The fastest light-driven current source

Controlling electronic current is essential to modern electronics, as data and signals are transferred by streams of electrons which are controlled at high speed. Demands on transmission speeds are also increasing as technology develops. Scientists from the Chair of Laser Physics and the Chair of Applied Physics at Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) have succeeded in switching on a current with a desired direction in graphene using a single laser pulse within a femtosecond ¬¬ – a femtosecond corresponds to the millionth part of a billionth of a second. This is more than a thousand times faster compared to the most efficient transistors today.

Graphene is up to the job

Im Focus: LaserTAB: More efficient and precise contacts thanks to human-robot collaboration

At the productronica trade fair in Munich this November, the Fraunhofer Institute for Laser Technology ILT will be presenting Laser-Based Tape-Automated Bonding, LaserTAB for short. The experts from Aachen will be demonstrating how new battery cells and power electronics can be micro-welded more efficiently and precisely than ever before thanks to new optics and robot support.

Fraunhofer ILT from Aachen relies on a clever combination of robotics and a laser scanner with new optics as well as process monitoring, which it has developed...

Im Focus: The pyrenoid is a carbon-fixing liquid droplet

Plants and algae use the enzyme Rubisco to fix carbon dioxide, removing it from the atmosphere and converting it into biomass. Algae have figured out a way to increase the efficiency of carbon fixation. They gather most of their Rubisco into a ball-shaped microcompartment called the pyrenoid, which they flood with a high local concentration of carbon dioxide. A team of scientists at Princeton University, the Carnegie Institution for Science, Stanford University and the Max Plank Institute of Biochemistry have unravelled the mysteries of how the pyrenoid is assembled. These insights can help to engineer crops that remove more carbon dioxide from the atmosphere while producing more food.

A warming planet

Im Focus: Highly precise wiring in the Cerebral Cortex

Our brains house extremely complex neuronal circuits, whose detailed structures are still largely unknown. This is especially true for the so-called cerebral cortex of mammals, where among other things vision, thoughts or spatial orientation are being computed. Here the rules by which nerve cells are connected to each other are only partly understood. A team of scientists around Moritz Helmstaedter at the Frankfiurt Max Planck Institute for Brain Research and Helene Schmidt (Humboldt University in Berlin) have now discovered a surprisingly precise nerve cell connectivity pattern in the part of the cerebral cortex that is responsible for orienting the individual animal or human in space.

The researchers report online in Nature (Schmidt et al., 2017. Axonal synapse sorting in medial entorhinal cortex, DOI: 10.1038/nature24005) that synapses in...

Im Focus: Tiny lasers from a gallery of whispers

New technique promises tunable laser devices

Whispering gallery mode (WGM) resonators are used to make tiny micro-lasers, sensors, switches, routers and other devices. These tiny structures rely on a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

Goodbye, login. Hello, heart scan

26.09.2017 | Information Technology

The material that obscures supermassive black holes

26.09.2017 | Physics and Astronomy

Ageless ears? Elderly barn owls do not become hard of hearing

26.09.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>